Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients

Molecular-targeted therapy has not been established in non-adenocarcinoma lung cancer (non-AdLC), as no targets that affect the clinical efficacy of molecular-targeted drugs have yet been identified. In this study, we investigated the frequency of genetic variations in discoidin domain receptor 2 (D...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: YASHIMA, HIDEAKI, SHIMIZU, KIMIHIRO, ARAKI, TAKUYA, AOMORI, TOHRU, OHTAKI, YOICHI, NAGASHIMA, TOSHITERU, ENOKIDA, YASUAKI, ATSUMI, JUN, NAKAMURA, TOMONORI, TAKEYOSHI, IZUMI, YAMAMOTO, KOUJIROU
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2014
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4106743/
https://ncbi.nlm.nih.gov/pubmed/25054035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.302
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы